SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MRS 2211 | sc-204101 sc-204101A | 10 mg 50 mg | $118.00 $463.00 | 2 | ||
MRS 2211 is a selective P2Y13 receptor agonist that showcases unique molecular interactions, particularly through its ability to stabilize receptor conformations. This compound engages in specific hydrogen bonding and hydrophobic interactions, enhancing its affinity for the receptor. Its kinetic profile indicates a rapid onset of action, influencing intracellular signaling pathways. The compound's structural features promote distinct allosteric modulation, providing insights into receptor dynamics and purinergic signaling mechanisms. | ||||||
MRS 2179 ammonium salt | 101204-49-3 | sc-253058 | 5 mg | $313.00 | 1 | |
By selectively antagonizing P2Y1 receptors, MRS 2179 may lead to a decrease in P2Y13 receptor expression through altered nucleotide signaling. | ||||||
Clopidogrel | 113665-84-2 | sc-507403 | 1 g | $122.00 | 1 | |
The active metabolites of Clopidogrel could decrease P2Y13 receptor expression by inhibiting P2Y12 receptors and thus reducing ADP-mediated responses that can upregulate P2Y13. | ||||||
Prasugrel | 150322-43-3 | sc-391536 | 100 mg | $79.00 | ||
Prasugrel, through its antiplatelet action, could reduce P2Y13 receptor expression by lowering the availability of ADP, a known P2Y13 agonist. | ||||||
Ticagrelor | 274693-27-5 | sc-472972 sc-472972A sc-472972B sc-472972C | 10 mg 25 mg 50 mg 100 mg | $104.00 $228.00 $270.00 $302.00 | ||
Ticagrelor inhibits P2Y12 receptors and could lead to a decreased expression of P2Y13 receptors by diminishing the ADP signaling that often upregulates P2Y13. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits PI3K, an upstream regulator of many signal transduction pathways; this inhibition could lead to decreased expression of P2Y13 receptors by altering transcriptional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that could decrease P2Y13 receptor expression by blocking the JNK signaling pathway, which is involved in the control of gene expression. | ||||||